Medical injector

Tyce October 26, 2

Patent Grant D626216

U.S. patent number D626,216 [Application Number D/274,154] was granted by the patent office on 2010-10-26 for medical injector. This patent grant is currently assigned to Sanofi-Aventis Deutschland GmbH. Invention is credited to Daniel Paul Charles Tyce.


United States Patent D626,216
Tyce October 26, 2010

Medical injector

Claims

CLAIM The ornamental design for the a medical injector, as shown and described.
Inventors: Tyce; Daniel Paul Charles (Warwickshire, GB)
Assignee: Sanofi-Aventis Deutschland GmbH (Frankfurt, DE)
Appl. No.: D/274,154
Filed: March 30, 2007

Foreign Application Priority Data

Oct 30, 2006 [EM] 000620851
Current U.S. Class: D24/114
Current International Class: 2402
Field of Search: ;D19/35,36,41,43,44,45,46,47,48,49,50,51,54,55,56,57 ;D24/108,112,113,114,130,133,138,146,147 ;604/187,188,189,197,198,207,208,227,229,232 ;606/181,182,185

References Cited [Referenced By]

U.S. Patent Documents
2398544 April 1946 Lockhart
3045593 July 1962 Petterson
3254836 June 1966 Corpian
4637403 January 1987 Garcia et al.
D289424 April 1987 Huang
4973318 November 1990 Holm et al.
D324070 February 1992 Suzuki
5334144 August 1994 Alchas et al.
5569214 October 1996 Chanoch
D390872 February 1998 Sunaga
D414201 September 1999 Larson et al.
D426299 June 2000 Bydlon et al.
D426572 June 2000 Salemme et al.
6110149 August 2000 Klitgaard et al.
D451138 November 2001 Rosenbaum
D462760 September 2002 Ahlgrim et al.
6454746 September 2002 Bydlon et al.
D479602 September 2003 Bainton
D479747 September 2003 Bainton
D479748 September 2003 Tyce
D483067 December 2003 Takanashi
D492027 June 2004 Tyce et al.
D492405 June 2004 Bainton
D501253 January 2005 Bainton
D502739 March 2005 Shova et al.
D503797 April 2005 Tyce
D505490 May 2005 Tyce
6932794 August 2005 Giambattista et al.
7018364 March 2006 Giambattista et al.
D540465 April 2007 Bainton
D567939 April 2008 Mattigka
7534222 May 2009 Sugita et al.
D599009 August 2009 Tyce
D599010 August 2009 Tyce
D600794 September 2009 Tyce
D600795 September 2009 Tyce
7621891 November 2009 Wyrick
2004/0106895 June 2004 Slate et al.
2004/0236284 November 2004 Hoste et al.
2005/0187523 August 2005 Giambattista et al.
2005/0234492 October 2005 Tsai et al.
2005/0251103 November 2005 Steffen et al.
2006/0155246 July 2006 Higuchi et al.
2006/0229570 October 2006 Lovell et al.
2007/0123829 May 2007 Atterbury et al.
2007/0129687 June 2007 Marshall et al.
2009/0076458 March 2009 Nielsen et al.

Other References

SoloStar disposable pen injector by DCA Design International for Sanofi Aventis GmbH, as shown on www.effectivedesign.org.uk, dated Oct. 22, 2009 (3 pages). cited by examiner .
DCA brochure for SoloStar disposable pen injector for insulin, as found on www.effectivedesign.org.uk, as indicated at arrow on Item "U" above, dated Jun. 2, 2009 (10 pages). Reference to date of product launch (2007) on p. 2, last paragraph. cited by examiner .
Article on www.diabeteshealth.com about FDA approval of Lantus SoloStar disposable insulin pen, with a picture of the product, dated May 4, 2007 (5 pages). cited by examiner.

Primary Examiner: Albert; Elizabeth A
Assistant Examiner: Eldridge Powers; Karen E
Attorney, Agent or Firm: Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.

Description



The file of this patent contains at least one photograph executed in color. Copies of this patent with color photographs will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a front plan view of the first embodiment of a medical injector of my new design;

FIG. 2 is a left side view thereof,

FIG. 3 is a rear view thereof;

FIG. 4 is a right side view thereof;

FIG. 5 is a bottom view thereof;

FIG. 6 is a top view thereof;

FIG. 7 is a front plan view of a second embodiment of a medical injector of my new design;

FIG. 8 is a left side view thereof,

FIG. 9 is a rear view thereof;

FIG. 10 is a right side view thereof;

FIG. 11 is a bottom view thereof; and,

FIG. 12 is a top view thereof.

The colors of the first embodiment of the design are as follows:

Body/Cap: Pantone: 16-3802 TPX (corresponds to light gray);

Dose dial grip: Pantone 18-4005 TPX (corresponds to dark gray);

Dose button/border of the label: Pantone 2645 (corresponds to violet blue); and

Surface of the label: no color (white).

* * * * *

References


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed